Ken,
Missed this news release on VASO yesterday. Would explain the late day volume and interest.
Joe
Wednesday November 21, 12:00 pm Eastern Time
Press Release
SOURCE: Vasomedical, Inc.
Vasomedical to be Featured On BusinessNow
TV Broadcast Scheduled for Sunday, November 25, 2001 At 10:30 AM EST
WESTBURY, N.Y.--(BW HealthWire)--Nov. 21, 2001--Vasomedical, Inc. (Nasdaq: VASO - news) announced today that the company would be featured in a segment of the business television program BusinessNow, this Sunday, November 25th at 10:30 AM on WABC-TV in New York.
BusinessNow is a fast-paced TV newsmagazine, sponsored by NEXTEL, that goes on location to explore today's innovative and growing companies. The Vasomedical segment will feature interviews with President and CEO D. Michael Deignan, Vice President of Marketing and Business Development Douglas A. Goldman, an EECP therapy provider and a noted industry analyst. BusinessNow is produced and distributed in major U.S. cities by, and is a wholly-owned subsidiary of, BNTV. For information about possible broadcast dates in other markets, visit the BusinessNow website at www.businessnow.com.
Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting external counterpulsation systems based on the Company's proprietary technology currently indicated for use in cases of angina, cardiogenic shock and acute myocardial infarction. EECP® is a registered trademark for Vasomedical's enhanced external counterpulsation system. This system is now in use at major medical centers, including the Beth Israel Medical Center - New York City, Christ Hospital and Medical Center, the Cleveland Clinic, Johns Hopkins, JFK Medical Center-Atlantis, FL, Mayo Clinic, the Miami Heart Institute, the Ochsner Foundation Hospital, the Texas Heart Institute, and University Hospital at UMDNJ/New Jersey Medical School as well as medical centers affiliated with Columbia University, State University of New York at Stony Brook, the University of Pittsburgh, the University of California at San Diego, the University of California at San Francisco, University of Florida at Gainesville, and the University of Virginia. The Company provides hospitals, clinics and private practices with EECP® equipment, treatment guidance and a staff training and maintenance program designed to provide optimal patient outcomes. Additional information is available on the Company's website at www.vasomedical.com.
Except for historical information contained in this release, the matters discussed are forward looking statements that involve risks and uncertainties. When used in this release, words such as ``anticipate,'' ``believe,'' ``estimate,'' ``expect''' and ``intend'' and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and pricing; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to revise any forward-looking statements as a result of future events or developments. |
